Hemophilia A and B are bleeding disorders involving reduced activity of clotting factor VIII or IX, respectively. They can cause prolonged bleeding after injury or procedures and, in more severe forms, spontaneous bleeding into joints, muscles or other sites. The type and clinical context matter for diagnosis and care. [1]
In this guide: What should prompt assessment? · How do clinicians distinguish A from B? · How do F8 and F9 fit? · Can women and girls have hemophilia symptoms? · Prevention and treatment answer different questions · Is every diagnosis of hemophilia inherited? · Read treatment headlines with a clear endpoint · Find evidence and professional care
What should prompt assessment?
Unusual bruising, prolonged bleeding, painful or swollen joints, and a family history of bleeding deserve medical assessment. Bleeding inside the head or other vital organs can be life-threatening. A person with hemophilia should follow their emergency plan and seek urgent medical assessment for significant head injury or suspected serious bleeding. [2]
For a non-emergency consultation, make a brief timeline: what happened, where bleeding occurred, how long it lasted, whether treatment was needed and whether it followed a procedure. Include dental and surgical experiences. A clear history is more informative than an isolated photograph of a bruise.
How do clinicians distinguish A from B?
Screening blood tests assess aspects of clotting; specific factor assays measure factor VIII and IX activity. These help identify the type and severity. In newborns, factor IX results require age-aware interpretation because a mildly low level at birth does not automatically establish hemophilia B. [3]
- Describe the bleeding history and relevant relatives.
- Keep the exact laboratory results, with units, date and reference information.
- Clarify which factor is affected and how the clinician classifies severity.
- Ask how genetic testing contributes to confirmation and family assessment.
- Agree a care and emergency plan before a planned procedure or travel.
How do F8 and F9 fit?
F8 is associated with hemophilia A; F9 with hemophilia B. Both conditions usually follow X-linked inheritance. The companion F8 and F9 gene guide explains why exact variant identification and test capabilities matter. Similar bleeding symptoms do not make the genes or factor products interchangeable. [1]
A family record should identify the confirmed type, the molecular finding if known, and the responsible treatment center. Avoid writing only “a blood disorder runs in the family.” The cascade testing guide explains how to build a focused testing question from an established familial result.
Can women and girls have hemophilia symptoms?
Yes. Females with an F8 or F9 pathogenic variant can have low factor activity and clinically important bleeding. Some females with an F8 variant report increased bleeding even with factor VIII activity in the normal range. The label carrier must not replace assessment of bleeding history and factor activity. [4][5]
Include menstrual, childbirth, surgical and dental bleeding in the history when relevant. Ask which information should be shared with the clinicians planning a procedure. Do not assume that a relative’s mild symptoms establish another person’s risk or that absence of previous surgery proves there is no bleeding tendency.
Prevention and treatment answer different questions
Care can be designed to prevent bleeding or to treat an episode. Factor replacement and other approaches work through different mechanisms; selection belongs with the treatment team. Comprehensive hemophilia centers combine hematology, nursing, physiotherapy and other support. [6]
Inhibitors are antibodies that can interfere with replacement factor treatment. Their presence can change management. The clinician should explain which tests and treatment plan apply, particularly if the usual response changes. [4][5]
- What is my written plan for suspected bleeding and emergencies?
- How should routine care be coordinated before dental work or surgery?
- How are joint health, pain and participation being assessed?
- Which symptoms or treatment responses require an early call?
- Are inhibitor testing and medication records up to date?
- How do I obtain supplies and specialist advice while away from home?
Is every diagnosis of hemophilia inherited?
No. Acquired hemophilia can develop later in life and differs from the usual inherited forms. A new bleeding problem therefore needs clinical investigation rather than an assumption that an F8 or F9 variant must be responsible. [2]
Find a specialist service and keep its contact available
In the United States, the CDC Hemophilia Treatment Center Directory lists centers and their contact details. Confirm the referral process and the team’s urgent-contact instructions. Outside the United States, ask the local clinician or national bleeding-disorders service for the corresponding center. Save the agreed contact with the existing emergency plan; a directory search is not a substitute for urgent care.
Read treatment headlines with a clear endpoint
Separate factor activity, annualized bleeding rate, joint outcomes, treatment burden and safety. Record the starting treatment and whether participants had inhibitors. “No treated bleeds” is not automatically the same outcome as “no bleeds,” and a short follow-up cannot establish lifelong durability.
For gene-therapy claims, use our trial-results guide. Ask the clinical team about current local eligibility, authorization and safety information. This article does not rank products or select a treatment.
Find evidence and professional care
Continue with the F8 and F9 gene guide. Use the variant research assistant, literature tools and care finder for structured research and professional directories. Keep any emergency plan available independently of this website.
Educational information, not an individual diagnosis or treatment plan. The current specialist-review status appears above. Illustrations are original educational examples, not patient records.